Institutionelles- und Fonds-Eigentümerschaft - Käufer
Zu den wichtigsten Inhabern, die neue Positionen in AgomAb Therapeutics NV - Depositary Receipt (Common Stock) eröffnet haben, gehören EQT Fund Management S.a r.l., Sanofi, Cormorant Asset Management, LP, TCG Crossover Management, LLC, Federated Hermes, Inc., Casdin Capital, LLC, Andera Partners, Fmr Llc, Nantahala Capital Management, LLC, Standard Life Aberdeen plc, Samsara BioCapital, LLC, Perceptive Advisors Llc, Siren, L.L.C., LMR Partners LLP, Seven Grand Managers, Llc, Redmile Group, LLC, Millennium Management Llc, Alyeska Investment Group, L.P., Pfizer Inc, und Laurion Capital Management LP .
Diese Seite zeigt Veränderungen in der Eigentümerstruktur, indem sie Institutionen, Fonds und Großaktionäre auflistet, die im letzten Berichtszeitraum ihre Bestände erhöht oder neue Positionen eröffnet haben. Grüne Zeilen weisen auf neue Positionen hin. Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen.
Upgradezum Freischalten von Premium-Daten.
| Datei Datum | Quelle | Anleger | Typ | Durchschnittlicher Preis (Est) |
Aktien | Δ Aktien (%) |
Gemeldeter Wert ($1000) |
Δ Wert (%) |
Port Alloc (%) |
|
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | 13F | Samsara BioCapital, LLC | 600.000 | 6.294 | ||||||
| 2026-05-15 | 13F | Burkehill Global Management, LP | 35.000 | 367 | ||||||
| 2026-05-15 | 13F | Fmr Llc | 1.458.677 | 15.302 | ||||||
| 2026-05-15 | 13F | Morgan Stanley | 3.025 | 32 | ||||||
| 2026-05-14 | 13F | Hrt Financial Lp | 23.726 | 0 | ||||||
| 2026-05-15 | 13F | Goldman Sachs Group Inc | 35.739 | 375 | ||||||
| 2026-05-15 | 13F | TCG Crossover Management, LLC | 2.053.233 | 21.538 | ||||||
| 2026-05-11 | 13F | Andera Partners | 1.538.702 | 16.141 | ||||||
| 2026-05-12 | 13F | Jane Street Group, Llc | 12.794 | 134 | ||||||
| 2026-05-05 | 13F | UBS Group AG | 6.437 | 68 | ||||||
| 2026-04-29 | 13F | Standard Life Aberdeen plc | 707.656 | 7.423 | ||||||
| 2026-05-15 | 13F | Cormorant Asset Management, LP | 2.465.348 | 25.862 | ||||||
| 2026-05-14 | 13F | Laurion Capital Management LP | 50.000 | 524 | ||||||
| 2026-05-15 | 13F | D. E. Shaw & Co., Inc. | 15.326 | 161 | ||||||
| 2026-05-11 | 13F | Federated Hermes, Inc. | 1.618.000 | 16.973 | ||||||
| 2026-05-15 | 13F | Two Sigma Investments, Lp | 14.241 | 149 | ||||||
| 2026-05-15 | 13F | Alyeska Investment Group, L.P. | 75.000 | 787 | ||||||
| 2026-05-14 | 13F | Siren, L.L.C. | 411.250 | 4.314 | ||||||
| 2026-05-07 | 13F | Sanofi | 2.783.096 | 29.195 | ||||||
| 2026-05-14 | 13F | EQT Fund Management S.a r.l. | 5.141.992 | 53.939 | ||||||
| 2026-04-28 | 13F | SBI Securities Co., Ltd. | 2 | 0 | ||||||
| 2026-05-15 | 13F | Casdin Capital, LLC | 1.550.000 | 16.260 | ||||||
| 2026-05-15 | 13F | Millennium Management Llc | 95.233 | 999 | ||||||
| 2026-05-15 | 13F | LMR Partners LLP | 300.000 | 3.147 | ||||||
| 2026-05-29 | 13F/A | Perceptive Advisors Llc | 600.000 | 6.294 | ||||||
| 2026-05-14 | 13F | Bellevue Group AG | 50.000 | 524 | ||||||
| 2026-05-15 | 13F | Redmile Group, LLC | 156.250 | 1.639 | ||||||
| 2026-05-15 | 13F | Citadel Advisors Llc | 35.000 | 367 | ||||||
| 2026-05-06 | 13F | Seven Grand Managers, Llc | 200.000 | 2.098 | ||||||
| 2026-05-15 | 13F | Sectoral Asset Management Inc | 43.500 | 477 | ||||||
| 2026-05-15 | 13F | Nantahala Capital Management, LLC | 1.200.000 | 12.852 | ||||||
| 2026-05-12 | 13F | Pfizer Inc | 75.000 | 814 |
